ProShares UltraShort Nasdaq Biotechnology (BIS) Short Interest Ratio & Short Volume $16.96 -0.14 (-0.82%) (As of 12/17/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipShort InterestTrends ProShares UltraShort Nasdaq Biotechnology Short Interest DataProShares UltraShort Nasdaq Biotechnology (BIS) has a short interest of 8,400 shares. This marks a -2.33% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.6, indicating that it would take 0.6 days of the average trading volume of 14,063 shares to cover all short positions.Current Short Interest8,400 sharesPrevious Short Interest8,600 sharesChange Vs. Previous Month-2.33%Dollar Volume Sold Short$132,972.00Short Interest Ratio0.6 Days to CoverLast Record DateNovember 30, 2024Outstanding Shares220,000 sharesPercentage of Shares Shorted3.82%Today's Trading Volume7,962 sharesAverage Trading Volume14,063 sharesToday's Volume Vs. Average57% Short Selling ProShares UltraShort Nasdaq Biotechnology? Sign up to receive the latest short interest report for ProShares UltraShort Nasdaq Biotechnology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBIS Short Interest Over TimeBIS Days to Cover Over TimeBIS Percentage of Float Shorted Over Time Ad Porter & CompanyHow to piss off your liberal friends… and profit from itElon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.To get the full details on the fake “energy crisis” of America, watch this now ProShares UltraShort Nasdaq Biotechnology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 11/30/20248,400 shares $132,972.00 -2.3%N/A0.6 $15.83 11/15/20248,600 shares $152,048.00 +32.3%N/A0.6 $17.68 10/31/20246,500 shares $103,740.00 -4.4%N/A0.5 $15.96 10/15/20246,800 shares $101,252.00 -20.0%N/A0.5 $14.89 9/30/20248,500 shares $127,840.00 -31.5%N/A0.6 $15.04 9/15/202412,400 shares $178,684.00 -30.7%N/A1 $14.41 Get the Latest News and Ratings for BIS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ProShares UltraShort Nasdaq Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 8/31/202417,900 shares $259,192.00 +103.4%N/A1.8 $14.48 8/15/20248,800 shares $133,760.00 -35.8%N/A1.1 $15.20 7/31/202413,700 shares $201,253.00 +20.2%N/A2 $14.69 7/15/202411,400 shares $168,746.22 -17.4%N/A1.9 $14.80 6/30/202413,800 shares $229,770.00 +43.8%N/A2.3 $16.65 6/15/20249,600 shares $163,881.60 -41.1%N/A1.4 $17.07 5/31/202416,300 shares $292,422.00 +29.4%N/A2.3 $17.94 5/15/202412,600 shares $219,114.00 -16.0%N/A1.8 $17.39 4/30/202415,000 shares $299,400.00 +11.9%N/A2 $19.96 4/15/202413,400 shares $268,670.00 -30.6%N/A0.7 $20.05 3/31/202419,300 shares $339,294.00 +144.3%N/A0.8 $17.58 3/15/20247,900 shares $143,622.00 -2.5%N/A0.3 $18.18 2/29/20248,100 shares $143,086.50 -35.2%N/A0.4 $17.67 2/15/202412,500 shares $220,125.00 +0.8%N/A0.6 $17.61 1/31/202412,400 shares $223,057.40 -10.1%N/A0.6 $17.99 1/15/202413,800 shares $238,188.00 +14.1%N/A1.5 $17.26 12/31/202312,100 shares $218,647.00 +40.7%N/A2.6 $18.07 12/15/20238,600 shares $169,076.00 -4.4%N/A1.8 $19.66 11/30/20239,000 shares $209,520.00 -8.2%N/A1.9 $23.28 11/15/20239,800 shares $239,120.00 -36.8%N/A1.9 $24.40 10/31/202315,500 shares $398,505.00 +23.0%N/A3.3 $25.71 10/15/202312,600 shares $284,760.00 -21.7%N/A3.6 $22.60 9/30/202316,100 shares $360,801.00 +11.0%N/A5 $22.41 9/15/202314,500 shares $309,285.00 -14.2%N/A4.7 $21.33 8/31/202316,900 shares $349,492.00 +59.4%N/A4.9 $20.68 8/15/202310,600 shares $220,904.00 No ChangeN/A2.9 $20.84 7/31/202310,600 shares $216,346.00 +17.8%N/A2.8 $20.41 7/15/20239,000 shares $186,120.00 -4.3%N/A2.3 $20.68 6/30/20239,400 shares $195,901.64 -2.1%N/A2.1 $20.84 6/15/20239,600 shares $184,608.00 -15.0%N/A1.5 $19.23 5/31/202311,300 shares $235,605.00 -15.7%N/A1.3 $20.85 5/15/202313,400 shares $255,538.00 -1.5%N/A1.2 $19.07 4/30/202313,600 shares $268,192.00 -20.0%N/A1.1 $19.72 4/15/202317,000 shares $329,800.00 -9.6%N/A1.2 $19.40Musk threatens Liberal’s fake “energy crisis” (Ad)Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.To get the full details on the fake “energy crisis” of America, watch this now 3/31/202318,800 shares $381,452.00 -42.5%N/A1.2 $20.29 3/15/202332,700 shares $694,875.00 +51.4%N/A1.6 $21.25 2/28/202321,600 shares $449,280.00 +67.4%N/A1.1 $20.80 2/15/202312,900 shares $247,422.00 -22.8%N/A0.6 $19.18 1/31/202316,700 shares $305,443.00 +12.1%N/A0.9 $18.29 1/15/202314,900 shares $271,776.00 -77.5%N/A0.8 $18.24 12/30/202266,300 shares $1.30 million +151.1%N/A3.7 $19.64 12/15/202226,400 shares $497,112.00 -65.1%N/A1.4 $18.83 11/30/202275,600 shares $1.40 million +132.6%N/A4.6 $18.55 11/15/202232,500 shares $625,300.00 -35.6%N/A2.1 $19.24 10/31/202250,500 shares $1.06 million -0.4%N/A3.2 $20.94 10/15/202250,700 shares $1.22 million No ChangeN/A2.2 $24.12 9/30/202246,500 shares $1.18 million -2.5%N/A1.6 $25.27 9/15/202247,700 shares $1.10 million +3.9%N/A1.7 $23.08 8/31/202245,900 shares $1.13 million +73.2%N/A1.5 $24.65 8/15/202226,500 shares $533,180.00 +150.0%N/A0.8 $20.12 7/31/202210,600 shares $260,866.00 -21.5%N/A0.3 $24.61 7/15/202213,500 shares $324,540.00 -84.6%N/A0.4 $24.04 6/30/202287,800 shares $2.37 million +644.1%N/A3.4 $26.95 6/15/202211,800 shares $381,494.00 -21.9%N/A0.5 $32.33 5/31/202215,100 shares $430,199.00 -36.0%N/A0.7 $28.49 5/15/202223,600 shares $724,756.00 +4.9%N/A1.1 $30.71 4/30/202222,500 shares $652,275.00 +14.2%N/A1.1 $28.99 4/15/202219,700 shares $457,040.00 +38.7%N/A0.9 $23.20 3/31/202214,200 shares $342,362.00 -21.6%N/A0.6 $24.11 3/15/202218,100 shares $511,325.00 -39.9%N/A0.7 $28.25 2/28/202230,100 shares $812,700.00 +2.4%N/A1.1 $27.00 2/15/202229,400 shares $743,526.00 -8.7%N/A1.1 $25.29 1/31/202232,200 shares $811,440.00 +35.9%N/A1.6 $25.20 1/15/202223,700 shares $546,059.85 +1.3%N/A1.3 $23.04 12/31/202123,400 shares $469,638.00 -2.1%N/A1.9 $20.07 12/15/202123,900 shares $480,151.00 -7.4%N/A2 $20.09 11/30/202125,800 shares $515,742.00 +80.4%N/A2.1 $19.99 11/15/202114,300 shares $282,209.07 No ChangeN/A1.6 $19.73 10/29/202114,300 shares $266,552.00 +14.4%N/A1.5 $18.64 10/15/202112,500 shares $238,250.00 -2.3%N/A1.2 $19.06 9/30/202112,800 shares $230,912.00 -15.2%N/A1.1 $18.04 9/15/202115,100 shares $250,056.00 -7.9%N/A1.1 $16.56 8/31/202116,400 shares $271,092.00 -23.0%N/A1.1 $16.53 8/13/202121,300 shares $366,786.00 -20.8%N/A1.1 $17.22 7/30/202126,900 shares $491,732.00 +12.1%N/A1.2 $18.28 7/15/202124,000 shares $470,880.00 +61.1%N/A1 $19.62 6/30/202114,900 shares $274,011.00 +19.2%N/A0.5 $18.39 6/15/202112,500 shares $243,500.00 -57.2%N/A0.4 $19.48 5/28/202129,200 shares $632,180.00 -10.7%N/A0.7 $21.65 5/14/202132,700 shares $766,749.60 +157.5%N/A0.6 $23.45 4/30/202112,700 shares $266,954.00 -5.9%N/A0.2 $21.02 4/15/202113,500 shares $299,025.00 -43.5%N/A0.1 $22.15 3/31/202123,900 shares $568,342.00 -4.8%N/A0.2 $23.78 3/15/202125,100 shares $542,411.00 -18.0%N/A0.3 $21.61Musk threatens Liberal’s fake “energy crisis” (Ad)Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.To get the full details on the fake “energy crisis” of America, watch this now 2/26/202130,600 shares $651,780.00 -22.7%N/A0.3 $21.30 2/12/202139,600 shares $729,036.00 -60.3%N/A0.5 $18.41 1/29/202199,800 shares $2.07 million +552.3%N/A1.5 $20.76 1/15/202115,300 shares $313,803.00 -27.5%N/A0.2 $20.51 12/31/202021,100 shares $490,575.00 -27.5%N/A0.4 $23.25 12/15/202029,100 shares $666,972.00 +54.0%N/A0.5 $22.92 11/30/202018,900 shares $503,307.00 +3.3%N/A0.3 $26.63 11/15/202018,300 shares $503,982.00 +34.6%N/A0.3 $27.54 10/30/202013,600 shares $428,264.00 -11.1%N/A0.2 $31.49 10/15/202015,300 shares $424,269.00 -18.6%N/A0 $27.73 9/30/202018,800 shares $582,314.96 +15.3%N/A0.2 $30.97 9/15/202013,900 shares $429,811.63 -14.7%N/A0.1 $30.92 8/31/202016,300 shares $517,036.00 -81.2%N/A0.2 $31.72 8/14/202086,800 shares $2.87 million -26.9%N/A1 $33.12 7/31/2020118,700 shares $3.88 million +9.9%N/A0.4 $32.68 7/15/2020108,000 shares $3.29 million +94.6%N/A0.4 $30.44 6/30/202055,500 shares $1.85 million +4.1%N/A0.3 $33.28 6/15/202053,300 shares $1.98 million -12.1%N/A0.3 $37.08 5/29/202060,600 shares $2.13 million +27.9%N/A0.4 $35.12 5/15/202047,400 shares $1.76 million +200.0%N/A0.3 $37.20 4/30/202015,800 shares $643,376.00 -42.3%N/A0.1 $40.72 4/15/202027,400 shares $1.30 million -57.2%N/A0.2 $47.60 3/31/202064,000 shares $633,600.00 +31.4%N/A0.4 $9.90 3/13/202048,700 shares $602,419.00 +5.0%N/A0.3 $12.37 2/28/202046,400 shares $831,952.00 +129.7%N/A0.4 $17.93 2/14/202020,200 shares $297,748.00 -42.5%N/A0.2 $14.74 1/31/202035,100 shares $481,221.00 -43.5%N/A0.4 $13.71 1/15/202062,100 shares $796,743.00 -7.9%N/A0.8 $12.83 12/31/201967,400 shares $960,450.00 -51.1%N/A0.9 $14.25 BIS Short Interest - Frequently Asked Questions What is ProShares UltraShort Nasdaq Biotechnology's current short interest? Short interest is the volume of ProShares UltraShort Nasdaq Biotechnology shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 8,400 shares of BIS short. Learn More on ProShares UltraShort Nasdaq Biotechnology's current short interest. What is a good short interest ratio for ProShares UltraShort Nasdaq Biotechnology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BIS shares currently have a short interest ratio of 1.0. Learn More on ProShares UltraShort Nasdaq Biotechnology's short interest ratio. Is ProShares UltraShort Nasdaq Biotechnology's short interest increasing or decreasing? ProShares UltraShort Nasdaq Biotechnology saw a decline in short interest in the month of November. As of November 30th, there was short interest totaling 8,400 shares, a decline of 2.3% from the previous total of 8,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does ProShares UltraShort Nasdaq Biotechnology's short interest compare to its competitors? Here is how the short interest of companies compare to ProShares UltraShort Nasdaq Biotechnology: JPMorgan Healthcare Leaders ETF (0.08%), First Trust Nasdaq Pharmaceuticals ETF (0.03%), Invesco Nasdaq Biotechnology ETF (0.05%), ProShares Ultra Nasdaq Biotechnology (0.30%), Invesco Dorsey Wright Healthcare Momentum ETF (0.03%), Invesco S&P SmallCap Health Care ETF (0.00%), VanEck Biotech ETF (0.89%), VanEck Pharmaceutical ETF (35.32%), and iShares Biotechnology ETF (22.30%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks. What does it mean to sell short ProShares UltraShort Nasdaq Biotechnology stock? Short selling BIS is an investing strategy that aims to generate trading profit from ProShares UltraShort Nasdaq Biotechnology as its price is falling. BIS shares are trading down $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ProShares UltraShort Nasdaq Biotechnology? A short squeeze for ProShares UltraShort Nasdaq Biotechnology occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BIS, which in turn drives the price of the stock up even further. How often is ProShares UltraShort Nasdaq Biotechnology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIS, twice per month. The most recent reporting period available is November, 30 2024. More Short Interest Resources from MarketBeat Related Companies JPMorgan Healthcare Leaders ETF Short Interest Data First Trust Nasdaq Pharmaceuticals ETF Short Interest Data Invesco Nasdaq Biotechnology ETF Short Interest Data ProShares Ultra Nasdaq Biotechnology Short Interest Data Invesco Dorsey Wright Healthcare Momentum ETF Short Interest Data Invesco S&P SmallCap Health Care ETF Short Interest Data VanEck Biotech ETF Short Interest Data VanEck Pharmaceutical ETF Short Interest Data iShares Biotechnology ETF Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BIS) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares UltraShort Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares UltraShort Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
